Search results

Frequently asked questions on the Mo-99 Manufacturing Facility and the ANSTO Nuclear Medicine project.

A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.

Highlights of the Energy Materials Project.

The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.

ANSTO has almost seventy years of experience in advancing an understanding of the management of spent nuclear fuel and delivering safe and reliable forms for radioactive waste. 

Neutron and gamma ghost imaging are important scientific developments reported in two publications, and the subject of an Australian Research Council Discovery Project grant awarded to a team that includes ANSTO scientists

Australia part of global renaissance in fusion power research symbolised by ITER experiment

Scientists at ANSTO characterise structures with atomic detail using probes such as x-rays, electrons, neutrons and ions.

A new nuclear medicine waste processing facility that showcases ANSTO Synroc technology is under construction.

Commitment to undertake health research.

A unique scientific capability comprising a single research platform for high-fidelity simulation, real-time dosimetry, and biological response data is available all from a neutron instrument.